LIVZON PHARMA (01513) has accumulated repurchased 9.426 million shares of A shares.
Lizhu Pharmaceutical (01513) announced that as of February 28, 2025, the company has completed the centralized auction trading...
LIVZON PHARMA (01513) announced that as of February 28, 2025, the company repurchased a total of 9.426 million A shares through centralized bidding trading, accounting for 1.03% of the total share capital. The highest purchase price was RMB 38.37 per share, the lowest price was RMB 35.18 per share, and the total amount of funds used was RMB 342 million (excluding transaction costs). The repurchase mentioned above complies with the company's established share repurchase program.
Related Articles
US Stock Market Move | Elmet Group (ELMT.US) debuts on the US stock market, opening with a more than 40% increase.
US Stock Market Move | Announcing the finalization of a $7.5 billion lease agreement, Applied Digital (APLD.US) surged more than 13%.
Warner Bros. Discovery shareholders approved the merger with Paramount Skydance, but still face antitrust scrutiny from the United States and the European Union.
US Stock Market Move | Elmet Group (ELMT.US) debuts on the US stock market, opening with a more than 40% increase.
US Stock Market Move | Announcing the finalization of a $7.5 billion lease agreement, Applied Digital (APLD.US) surged more than 13%.
Warner Bros. Discovery shareholders approved the merger with Paramount Skydance, but still face antitrust scrutiny from the United States and the European Union.
RECOMMEND
The Great Transformation Of The Hong Kong Automotive Market
23/04/2026
Another “Elephant” Dances As China Construction Bank Hits A Record High While The Sector Remains Below Book Value, With Several Names Offering Elevated Dividend Yields
23/04/2026
Major Oil Traders Warn One Billion Barrel Shortfall Is Locked In, Hormuz Closure Could Trigger Recession
23/04/2026
